{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T14:16:27Z","timestamp":1790691387553,"version":"4.1.0"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2017,7,21]],"date-time":"2017-07-21T00:00:00Z","timestamp":1500595200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2017,7,21]],"date-time":"2017-07-21T00:00:00Z","timestamp":1500595200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Farber disease (FD) is a rare autosomal recessive disease caused by mutations in the acid ceramidase gene (<jats:italic>ASAH1<\/jats:italic>). Low ceramidase activity results in the accumulation of fatty substances, mainly ceramides. Hallmark symptoms at clinical level are periarticular nodules, lipogranulomas, swollen and painful joints and a hoarse voice. FD phenotypes are heterogeneous varying from mild to very severe cases, with the patients not surviving past their first year of life. The diagnostic aspects of FD are poorly developed due to the rarity of the disease. In the present study, the screening for ceramides and related molecules was performed in Farber affected patients (n\u2009=\u200910), carriers (n\u2009=\u200911) and control individuals (n\u2009=\u2009192). This study has the highest number of enrolled Farber patients and carriers reported to present. Liquid chromatography multiple reaction mass spectrometry (LC\/MRM-MS) studies revealed that the ceramide C26:0 and especially its isoform 1 is a highly sensitive and specific biomarker for FD (p\u2009&lt;\u20090.0001). The new biomarker can be determined directly in the dried blood spot extracts with low sample consumption. This allows for easy sample preparation, high reproducibility and use in high throughput screenings.<\/jats:p>","DOI":"10.1038\/s41598-017-06604-2","type":"journal-article","created":{"date-parts":[[2017,7,17]],"date-time":"2017-07-17T11:37:44Z","timestamp":1500291464000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":38,"title":["C26-Ceramide as highly sensitive biomarker for the diagnosis of Farber Disease"],"prefix":"10.1038","volume":"7","author":[{"given":"Claudia","family":"Cozma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marius-Ionu\u021b","family":"Iura\u0219cu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabrina","family":"Eichler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina","family":"Hovakimyan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oliver","family":"Brandau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susanne","family":"Zielke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tobias","family":"B\u00f6ttcher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne-Katrin","family":"Giese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Lukas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arndt","family":"Rolfs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,7,21]]},"reference":[{"key":"6604_CR1","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1002\/emmm.201302781","volume":"5","author":"MS Sands","year":"2013","unstructured":"Sands, M. S. Farber disease: understanding a fatal childhood disorder and dissecting ceramide biology. EMBO Mol. Med. \n                           5, 799\u2013801 (2013).","journal-title":"EMBO Mol. Med."},{"key":"6604_CR2","doi-asserted-by":"publisher","first-page":"1100","DOI":"10.1126\/science.178.4065.1100","volume":"178","author":"M Sugita","year":"1972","unstructured":"Sugita, M., Dulaney, J. T. & Moser, H. W. Ceramidase deficiency in Farber\u2019s disease (lipogranulomatosis). Science \n                           178, 1100\u20131102 (1972).","journal-title":"Science"},{"key":"6604_CR3","doi-asserted-by":"publisher","first-page":"2133","DOI":"10.1016\/j.bbamem.2006.08.019","volume":"1758","author":"J-H Park","year":"2006","unstructured":"Park, J.-H. & Schuchman, E. H. Acid ceramidase and human disease. Biochim. Biophys. Acta \n                           1758, 2133\u20132138 (2006).","journal-title":"Biochim. Biophys. Acta"},{"key":"6604_CR4","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1006\/geno.1999.5940","volume":"62","author":"CM Li","year":"1999","unstructured":"Li, C. M. et al. The human acid ceramidase gene (ASAH): structure, chromosomal location, mutation analysis, and expression. Genomics \n                           62, 223\u2013331 (1999).","journal-title":"Genomics"},{"key":"6604_CR5","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/1546-0096-5-15","volume":"5","author":"K Ehlert","year":"2007","unstructured":"Ehlert, K. et al. Farber disease: clinical presentation, pathogenesis and a new approach to treatment. Pediatr. Rheumatol. Online J. \n                           5, 15 (2007).","journal-title":"Pediatr. Rheumatol. Online J."},{"key":"6604_CR6","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1515\/hsz-2014-0290","volume":"396","author":"M Frohbergh","year":"2015","unstructured":"Frohbergh, M., He, X. & Schuchman, E. H. The molecular medicine of acid ceramidase. Biol. Chem. \n                           396, 759\u2013765 (2015).","journal-title":"Biol. Chem."},{"key":"6604_CR7","doi-asserted-by":"publisher","first-page":"8303","DOI":"10.1021\/ac501937d","volume":"86","author":"EE Jones","year":"2014","unstructured":"Jones, E. E. et al. On-Tissue Localization of Ceramides and Other Sphingolipids by MALDI Mass Spectrometry Imaging. Anal. Chem. \n                           86, 8303\u20138311 (2014).","journal-title":"Anal. Chem."},{"key":"6604_CR8","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1002\/emmm.201202301","volume":"5","author":"AM Alayoubi","year":"2013","unstructured":"Alayoubi, A. M. et al. Systemic ceramide accumulation leads to severe and varied pathological consequences. EMBO Mol. Med. \n                           5, 827\u2013842 (2013).","journal-title":"EMBO Mol. Med."},{"key":"6604_CR9","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1007\/8904_2013_246","volume":"12","author":"NS Ferreira","year":"2014","unstructured":"Ferreira, N. S. et al. Accumulation of ordered ceramide-cholesterol domains in farber disease fibroblasts. JIMD Rep. \n                           12, 71\u201377 (2014).","journal-title":"JIMD Rep."},{"key":"6604_CR10","doi-asserted-by":"publisher","first-page":"2052","DOI":"10.1158\/1535-7163.MCT-11-0365","volume":"10","author":"JM Draper","year":"2011","unstructured":"Draper, J. M. et al. Discovery and Evaluation of Inhibitors of Human Ceramidase. Mol. Cancer Ther. \n                           10, 2052\u20132061 (2011).","journal-title":"Mol. Cancer Ther."},{"key":"6604_CR11","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1093\/alcalc\/ags106","volume":"48","author":"T Ramirez","year":"2013","unstructured":"Ramirez, T. et al. Insulin resistance, ceramide accumulation and endoplasmic reticulum stress in experimental chronic alcohol-induced steatohepatitis. Alcohol Alcohol. \n                           48, 39\u201352 (2013).","journal-title":"Alcohol Alcohol."},{"key":"6604_CR12","doi-asserted-by":"publisher","first-page":"337","DOI":"10.2337\/db08-1228","volume":"58","author":"JM Haus","year":"2009","unstructured":"Haus, J. M. et al. Plasma ceramides are elevated in obese subjects with type 2 diabetes and correlate with the severity of insulin resistance. Diabetes \n                           58, 337\u2013343 (2009).","journal-title":"Diabetes"},{"key":"6604_CR13","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1002\/1098-2264(2000)9999:9999<::AID-GCC1018>3.0.CO;2-E","volume":"29","author":"RS Seelan","year":"2000","unstructured":"Seelan, R. S. et al. Human acid ceramidase is overexpressed but not mutated in prostate cancer. Genes. Chromosomes Cancer \n                           29, 137\u2013146 (2000).","journal-title":"Genes. Chromosomes Cancer"},{"key":"6604_CR14","first-page":"65","volume":"25","author":"S Mathias","year":"1993","unstructured":"Mathias, S. & Kolesnick, R. Ceramide: a novel second messenger. Adv. Lipid Res. \n                           25, 65\u201390 (1993).","journal-title":"Adv. Lipid Res."},{"key":"6604_CR15","first-page":"913","volume":"81","author":"DI Kuzmenko","year":"2016","unstructured":"Kuzmenko, D. I. & Klimentyeva, T. K. Role of ceramide in apoptosis and development of insulin resistance. Biochem. \n                           81, 913\u2013927 (2016).","journal-title":"Biochem."},{"key":"6604_CR16","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/S0005-2760(98)00145-3","volume":"1436","author":"DK Perry","year":"1998","unstructured":"Perry, D. K. & Hannun, Y. A. The role of ceramide in cell signaling. Biochim. Biophys. Acta - Mol. Cell Biol. Lipids \n                           1436, 233\u2013243 (1998).","journal-title":"Biochim. Biophys. Acta - Mol. Cell Biol. Lipids"},{"key":"6604_CR17","first-page":"42","volume":"42","author":"M Koga","year":"1992","unstructured":"Koga, M., Ishihara, T., Uchino, F. & Fujiwaki, T. An autopsy case of Farber\u2019s lipogranulomatosis in a Japanese boy with gastrointestinal involvement. Acta Pathol. Jpn. \n                           42, 42\u201348 (1992).","journal-title":"Acta Pathol. Jpn."},{"key":"6604_CR18","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1007\/BF01600282","volume":"420","author":"L Zappatini-Tommasi","year":"1992","unstructured":"Zappatini-Tommasi, L., Dumontel, C., Guibaud, P. & Girod, C. Farber disease: an ultrastructural study. Report of a case and review of the literature. Virchows Arch. A. Pathol. Anat. Histopathol. \n                           420, 281\u2013290 (1992).","journal-title":"Virchows Arch. A. Pathol. Anat. Histopathol."},{"key":"6604_CR19","first-page":"816","volume":"24","author":"S Farber","year":"1957","unstructured":"Farber, S., Cohen, J. & Uzman, L. Lipogranulomatosis: a new lipo-glycoprotein \u2018Storage\u2019 disease. J. Mt. Sinai Hosp. N.Y. \n                           24, 816\u2013837 (1957).","journal-title":"J. Mt. Sinai Hosp. N.Y."},{"key":"6604_CR20","doi-asserted-by":"publisher","first-page":"1533","DOI":"10.1093\/rheumatology\/keu010","volume":"53","author":"M Torcoletti","year":"2014","unstructured":"Torcoletti, M. et al. Farber disease in infancy resembling juvenile idiopathic arthritis: identification of two new mutations and a good early response to allogeneic haematopoietic stem cell transplantation. Rheumatology (Oxford). \n                           53, 1533\u20131534 (2014).","journal-title":"Rheumatology (Oxford)."},{"key":"6604_CR21","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1007\/s10545-012-9573-z","volume":"36","author":"MM Kostik","year":"2013","unstructured":"Kostik, M. M. et al. Farber lipogranulomatosis with predominant joint involvement mimicking juvenile idiopathic arthritis. J. Inherit. Metab. Dis. \n                           36, 1079\u20131080 (2013).","journal-title":"J. Inherit. Metab. Dis."},{"key":"6604_CR22","doi-asserted-by":"publisher","first-page":"1533","DOI":"10.1093\/rheumatology\/keu010","volume":"53","author":"M Torcoletti","year":"2014","unstructured":"Torcoletti, M. et al. Farber disease in infancy resembling juvenile idiopathic arthritis: Identification of two new mutations and a good early response to allogeneic haematopoietic stem cell transplantation. Rheumatology (United Kingdom) \n                           53, 1533\u20131534 (2014).","journal-title":"Rheumatology (United Kingdom)"},{"key":"6604_CR23","doi-asserted-by":"publisher","first-page":"2001","DOI":"10.1194\/jlr.D005322","volume":"51","author":"M Scherer","year":"2010","unstructured":"Scherer, M., Leuth\u00e4user-Jaschinski, K., Ecker, J., Schmitz, G. & Liebisch, G. A rapid and quantitative LC-MS\/MS method to profile sphingolipids. J. Lipid Res. \n                           51, 2001\u20132011 (2010).","journal-title":"J. Lipid Res."},{"key":"6604_CR24","doi-asserted-by":"publisher","first-page":"1692","DOI":"10.1194\/jlr.D800051-JLR200","volume":"50","author":"RL Shaner","year":"2009","unstructured":"Shaner, R. L. et al. Quantitative analysis of sphingolipids for lipidomics using triple quadrupole and quadrupole linear ion trap mass spectrometers. J. Lipid Res. \n                           50, 1692\u20131707 (2009).","journal-title":"J. Lipid Res."},{"key":"6604_CR25","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1016\/S1044-0305(02)00358-6","volume":"13","author":"F-F Hsu","year":"2002","unstructured":"Hsu, F.-F. & Turk, J. Characterization of ceramides by low energy collisional-activated dissociation tandem mass spectrometry with negative-ion electrospray ionization. J. Am. Soc. Mass Spectrom. \n                           13, 558\u2013570 (2002).","journal-title":"J. Am. Soc. Mass Spectrom."},{"key":"6604_CR26","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/j.ab.2010.02.023","volume":"401","author":"T Kasumov","year":"2010","unstructured":"Kasumov, T. et al. Quantification of ceramide species in biological samples by liquid chromatography electrospray ionization tandem mass spectrometry. Anal. Biochem. \n                           401, 154\u2013161 (2010).","journal-title":"Anal. Biochem."},{"key":"6604_CR27","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/S0022-2275(20)36799-7","volume":"15","author":"M Sugita","year":"1974","unstructured":"Sugita, M. et al. High performance liquid chromatography of ceramides: application to analysis in human tissues and demonstration of ceramide excess in Farber\u2019s disease. J Lipid Res \n                           15, 223\u2013226 (1974).","journal-title":"J Lipid Res"},{"key":"6604_CR28","doi-asserted-by":"publisher","first-page":"337","DOI":"10.2337\/db08-1228","volume":"58","author":"JM Haus","year":"2009","unstructured":"Haus, J. M. et al. Plasma Ceramides Are Elevated in Obese Subjects With Type 2 Diabetes and Correlate With the Severity of Insulin Resistance. Diabetes \n                           58, 337\u2013343 (2009).","journal-title":"Diabetes"},{"key":"6604_CR29","doi-asserted-by":"publisher","first-page":"e141","DOI":"10.1038\/nutd.2014.38","volume":"4","author":"H Hanamatsu","year":"2014","unstructured":"Hanamatsu, H. et al. Altered levels of serum sphingomyelin and ceramide containing distinct acyl chains in young obese adults. Nutr. Diabetes \n                           4, e141 (2014).","journal-title":"Nutr. Diabetes"},{"key":"6604_CR30","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1038\/nrm2329","volume":"9","author":"YA Hannun","year":"2008","unstructured":"Hannun, Y. A. & Obeid, L. M. Principles of bioactive lipid signalling: lessons from sphingolipids. Nat. Rev. Mol. Cell Biol. \n                           9, 139\u2013150 (2008).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"6604_CR31","doi-asserted-by":"publisher","first-page":"1459","DOI":"10.1016\/j.bbadis.2016.05.001","volume":"1862","author":"EH Schuchman","year":"2016","unstructured":"Schuchman, E. H. Acid ceramidase and the treatment of ceramide diseases: The expanding role of enzyme replacement therapy. Biochim. Biophys. Acta - Mol. Basis Dis. \n                           1862, 1459\u20131471 (2016).","journal-title":"Biochim. Biophys. Acta - Mol. Basis Dis."},{"key":"6604_CR32","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1006\/abio.1996.9891","volume":"244","author":"N Mano","year":"1997","unstructured":"Mano, N., Oda, Y., Yamada, K., Asakawa, N. & Katayama, K. Simultaneous quantitative determination method for sphingolipid metabolites by liquid chromatography\/ionspray ionization tandem mass spectrometry. Anal. Biochem. \n                           244, 291\u2013300 (1997).","journal-title":"Anal. Biochem."},{"key":"6604_CR33","doi-asserted-by":"publisher","first-page":"8303","DOI":"10.1021\/ac501937d","volume":"86","author":"EE Jones","year":"2014","unstructured":"Jones, E. E. et al. On-tissue localization of ceramides and other sphingolipids by MALDI mass spectrometry imaging. Anal. Chem. \n                           86, 8303\u20138311 (2014).","journal-title":"Anal. Chem."},{"key":"6604_CR34","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1093\/jb\/mvs105","volume":"152","author":"A Kihara","year":"2012","unstructured":"Kihara, A. Very long-chain fatty acids: elongation, physiology and related disorders. J. Biochem. \n                           152, 387\u2013395 (2012).","journal-title":"J. Biochem."},{"key":"6604_CR35","doi-asserted-by":"publisher","first-page":"1338","DOI":"10.1172\/JCI115439","volume":"88","author":"WM Holleran","year":"1991","unstructured":"Holleran, W. M. et al. Sphingolipids are required for mammalian epidermal barrier function: Inhibition of sphingolipid synthesis delays barrier recovery after acute perturbation. J. Clin. Invest. \n                           88, 1338\u20131345 (1991).","journal-title":"J. Clin. Invest."},{"key":"6604_CR36","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1016\/j.biochi.2009.04.001","volume":"91","author":"Y Mizutani","year":"2009","unstructured":"Mizutani, Y., Mitsutake, S., Tsuji, K., Kihara, A. & Igarashi, Y. Ceramide biosynthesis in keratinocyte and its role in skin function. Biochimie \n                           91, 784\u2013790 (2009).","journal-title":"Biochimie"},{"key":"6604_CR37","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1001\/archderm.1994.01690040056007","volume":"130","author":"S Motta","year":"1994","unstructured":"Motta, S. et al. Abnormality of water barrier function in psoriasis. Role of ceramide fractions. Arch. Dermatol. \n                           130, 452\u2013456 (1994).","journal-title":"Arch. Dermatol."},{"key":"6604_CR38","doi-asserted-by":"publisher","first-page":"2066","DOI":"10.1161\/STROKEAHA.112.650390","volume":"43","author":"FD Testai","year":"2012","unstructured":"Testai, F. D. et al. Changes in the cerebrospinal fluid ceramide profile after subarachnoid hemorrhage. Stroke \n                           43, 2066\u20132070 (2012).","journal-title":"Stroke"},{"key":"6604_CR39","doi-asserted-by":"publisher","first-page":"2625","DOI":"10.1172\/JCI43068","volume":"121","author":"JC Perman","year":"2011","unstructured":"Perman, J. C. et al. The VLDL receptor promotes lipotoxicity and increases mortality in mice following an acute myocardial infarction. J. Clin. Invest. \n                           121, 2625\u20132640 (2011).","journal-title":"J. Clin. Invest."},{"key":"6604_CR40","doi-asserted-by":"publisher","unstructured":"Hammad, S. M. et al. Increased Plasma Levels of Select Deoxy-ceramide and Ceramide Species are Associated with Increased Odds of Diabetic Neuropathy in Type 1 Diabetes: A Pilot Study. Neuromolecular Med., doi:10.1007\/s12017-016-8423-9 (2016).","DOI":"10.1007\/s12017-016-8423-9"},{"key":"6604_CR41","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1038\/labinvest.3780005","volume":"80","author":"A Janssen","year":"2000","unstructured":"Janssen, A. et al. Docosahexaenoic acid deficit is not a major pathogenic factor in peroxisome-deficient mice. Lab. Invest. \n                           80, 31\u201335 (2000).","journal-title":"Lab. Invest."},{"key":"6604_CR42","doi-asserted-by":"crossref","first-page":"1632","DOI":"10.1093\/clinchem\/39.8.1632","volume":"39","author":"RBH Schutgens","year":"1993","unstructured":"Schutgens, R. B. H., Bouman, I. W., Nijenhuis, A. A., Wanders, R. J. A. & Frumau, M. E. J. Profiles of very-long-chain fatty acids in plasma, fibroblasts, and blood cells in Zellweger syndrome, X-linked adrenoleukodystrophy, and rhizomelic chondrodysplasia punctata. Clin. Chem. \n                           39, 1632\u20131637 (1993).","journal-title":"Clin. Chem."},{"key":"6604_CR43","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1042\/bj2050419","volume":"205","author":"T Momoi","year":"1982","unstructured":"Momoi, T., Ben-Yoseph, Y. & Nadler, H. L. Substrate-specificities of acid and alkaline ceramidases in fibroblasts from patients with Farber disease and controls. Biochem. J. \n                           205, 419\u2013425 (1982).","journal-title":"Biochem. J."},{"key":"6604_CR44","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1194\/jlr.M022186","volume":"53","author":"S Epstein","year":"2012","unstructured":"Epstein, S. et al. Activation of the unfolded protein response pathway causes ceramide accumulation in yeast and INS-1E insulinoma cells. J. Lipid Res. \n                           53, 412\u2013420 (2012).","journal-title":"J. Lipid Res."},{"key":"6604_CR45","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1126\/science.1168532","volume":"324","author":"V Menuz","year":"2009","unstructured":"Menuz, V. et al. Protection of C. elegans from anoxia by HYL-2 ceramide synthase. Science \n                           324, 381\u2013384 (2009).","journal-title":"Science"},{"key":"6604_CR46","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1016\/j.pharep.2015.12.008","volume":"68","author":"K Bienias","year":"2016","unstructured":"Bienias, K., Fiedorowicz, A., Sadowska, A., Prokopiuk, S. & Car, H. Regulation of sphingomyelin metabolism. Pharmacol. Reports \n                           68, 570\u2013581 (2016).","journal-title":"Pharmacol. Reports"},{"key":"6604_CR47","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1016\/j.neuropharm.2016.08.011","volume":"110","author":"N Hashimoto","year":"2016","unstructured":"Hashimoto, N. et al. Cholesterol-dependent increases in glucosylceramide synthase activity in Niemann-Pick disease type C model cells: Abnormal trafficking of endogenously formed ceramide metabolites by inhibition of the enzyme. Neuropharmacology \n                           110, 458\u2013469 (2016).","journal-title":"Neuropharmacology"},{"key":"6604_CR48","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1016\/0005-2760(80)90116-2","volume":"619","author":"PG Pentchev","year":"1980","unstructured":"Pentchev, P. G. et al. A lysosomal storage disorder in mice characterized by a dual deficiency of sphingomyelinase and glucocerebrosidase. Biochim. Biophys. Acta \n                           619, 669\u201379 (1980).","journal-title":"Biochim. Biophys. Acta"},{"key":"6604_CR49","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/1750-1172-5-16","volume":"5","author":"MT Vanier","year":"2010","unstructured":"Vanier, M. T. et al. Niemann-Pick disease type C. Orphanet J. Rare Dis. \n                           5, 16 (2010).","journal-title":"Orphanet J. Rare Dis."},{"key":"6604_CR50","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/0009-8981(94)05970-4","volume":"234","author":"T Fujiwaki","year":"1995","unstructured":"Fujiwaki, T. et al. Tissue accumulation of sulfatide and GM3 ganglioside in a patient with variant Farber disease. Clin. Chim. Acta. \n                           234, 23\u201336 (1995).","journal-title":"Clin. Chim. Acta."},{"key":"6604_CR51","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1111\/cge.12316","volume":"86","author":"MD Bashyam","year":"2014","unstructured":"Bashyam, M. D. et al. Molecular analyses of novel ASAH1 mutations causing Farber lipogranulomatosis: Analyses of exonic splicing enhancer inactivating mutation. Clin. Genet. \n                           86, 530\u2013538 (2014).","journal-title":"Clin. Genet."},{"key":"6604_CR52","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1002\/humu.5","volume":"17","author":"J B\u00e4r","year":"2001","unstructured":"B\u00e4r, J. et al. Molecular analysis of acid ceramidase deficiency in patients with Farber disease. Hum. Mutat. \n                           17, 199\u2013209 (2001).","journal-title":"Hum. Mutat."},{"key":"6604_CR53","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1111\/cge.12307","volume":"86","author":"DA Dyment","year":"2014","unstructured":"Dyment, D. A. et al. Evidence for clinical, genetic and biochemical variability in spinal muscular atrophy with progressive myoclonic epilepsy. Clin. Genet. \n                           86, 558\u2013563 (2014).","journal-title":"Clin. Genet."},{"key":"6604_CR54","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1016\/j.ymgme.2013.04.019","volume":"109","author":"MQ Alves","year":"2013","unstructured":"Alves, M. Q. et al. Molecular basis of acid ceramidase deficiency in a neonatal form of Farber disease: Identification of the first large deletion in ASAH1 gene. Mol. Genet. Metab. \n                           109, 276\u2013281 (2013).","journal-title":"Mol. Genet. Metab."},{"key":"6604_CR55","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1373\/clinchem.2008.111864","volume":"55","author":"VR De Jesus","year":"2009","unstructured":"De Jesus, V. R. et al. Development and Evaluation of Quality Control Dried Blood Spot Materials in Newborn Screening for Lysosomal Storage Disorders. Clin. Chem. \n                           55, 158\u2013164 (2009).","journal-title":"Clin. Chem."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-06604-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-06604-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-06604-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,23]],"date-time":"2022-12-23T07:21:28Z","timestamp":1671780088000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-06604-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,7,21]]},"references-count":55,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2017,12]]}},"alternative-id":["6604"],"URL":"https:\/\/doi.org\/10.1038\/s41598-017-06604-2","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,7,21]]},"assertion":[{"value":"24 November 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 June 2017","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 July 2017","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Claudia Cozma, Marius-Ionu\u021b Iura\u0219cu, Sabrina Eichler, Marina Hovakimyan, Oliver Brandau, Tobias B\u00f6ttcher and Arndt Rolfs are employees of Centogene AG.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"6149"}}